Promote Sponsor
verified SJR 0,722 · Q2 • database Scopus / SJR & Web of Science & DOAJ & Latindex indexed
PPAR Research
United States · John Wiley and Sons Ltd
workspace_premium Q2 — Drug Discovery verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ Unclaimed

PPAR Research

PPAR Research is a journal indexed in SJR in Drug Discovery and Pharmacology (medical) with an H index of 62. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1170 €. The scope of the journal is focused on PPAR alpha, PPAR-beta, PPAR delta, PPAR gamma, peroxisome proliferator-activated receptors. It has an SJR impact factor of 0,722 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,722.

ISSN: 1687-4757
Editorial: John Wiley and Sons Ltd
Category: Drug Discovery
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ verifiedLatindex

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guía para Autores (Guidelines)
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
0,722 Q2
H-index 62
Tasa de Aceptación pie_chart
30% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
12 semanas
Campo Average_time_publication_weeks
Coste de Publicación (APC) payments
1.170 € Open Access
Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science DOAJ Latindex

SJR Impact

0,722

H-index

62

Docs (year)

2

Docs 3y

55

Total refs

100

Cites 3y

150

Citable 3y

55

Cites/Doc 2y

2.93

Ref/Doc

50.0

Immediate OA

1170 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma

View more

WY-14643, a Potent Peroxisome Proliferator Activator Receptor-a PPAR-a Agonist Ameliorates the Inflammatory Process Associated to Experimental Periodontitis

View more

Identification of a Gene Sharing a Promoter and Peroxisome Proliferator-Response Elements With Acyl-CoA Oxidase Gene

View more

High Glucose Induces Autophagy through PPAR gamma-Dependent Pathway in Human Nucleus Pulposus Cells

View more

Hexarelin Signaling to PPAR gammain Metabolic Diseases

View more

Genetic Variation of PPARs

View more

Gene Expression Profiling in Wild-Type and PPAR-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPAR-Independent Effects

View more

Fine-Tuning Reception in the Bone: PPAR gammaand Company

View more

Fasting Upregulates PPAR Target Genes in Brain and Influences Pituitary Hormone Expression in a PPAR Dependent Manner

View more

Expression of Concern on "Testosterone Replacement Modulates Cardiac Metabolic Remodeling after Myocardial Infarction by Upregulating PPARa"

View more

Examination of Ligand-Dependent Coactivator Recruitment by Peroxisome Proliferator-Activated Receptor-a(PPARa)

View more

Diabetes, TZDs, and Bone: A Review of the Clinical Evidence

View more
SHOW MORE ARTICLES

Decrease of PPARdin Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury

View more

A Retrospective on Nuclear Receptor Regulation of Inflammation: Lessons from GR and PPARs

View more

Cryptochrome and Period Proteins Are Regulated by the CLOCK/BMAL1 Gene: Crosstalk between the PPARs/RXR-Regulated and CLOCK/BMAL1-Regulated Systems

View more

Consequences of PPARaInvalidation on Glutathione Synthesis: Interactions with Dietary Fatty Acids

View more

Combination Therapy of PPAR Ligands and Inhibitors of Arachidonic Acid in Lung Cancer

View more

Cardiomyocyte-Restricted Deletion of PPARbeta/din PPARa-Null Mice Causes Impaired Mitochondrial Biogenesis and Defense, but No Further Depression of Myocardial Fatty Acid Oxidation

View more

Cardiac PPARaProtein Expression is Constant as Alternate Nuclear Receptors and PGC-1 Coordinately Increase During the Postnatal Metabolic Transition

View more

Association of PPAR Alpha Intron 7 G/C, PPAR Gamma 2 Pro12Ala, and C161T Polymorphisms with Serum Fetuin-A Concentrations

View more

Activating Effect of Benzbromarone, a Uricosuric Drug, on Peroxisome Proliferator-Activated Receptors

View more

Activated PPAR gammaTargets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells

View more

ACitrus bergamiaExtract Decreases Adipogenesis and Increases Lipolysis by Modulating PPAR Levels in Mesenchymal Stem Cells from Human Adipose Tissue

View more

A Role for PPAR in Ocular Angiogenesis

View more

FAQS